These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Therapy for Graves' ophthalmopathy]. Zheng J; Zhang X; Gong R; Wang J; Tan T Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Oct; 21(5):876-9. PubMed ID: 15553880 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis of exophthalmos using orbital ultrasonography and treatment of malignant exophthalmos with steroid therapy, orbital radiation therapy, and plasmapheresis. Yamamoto K; Saito K; Takai T; Yoshida S Prog Clin Biol Res; 1983; 116():189-205. PubMed ID: 6134291 [TBL] [Abstract][Full Text] [Related]
7. Graves' disease of the orbit. Weber AL; Dallow RL; Sabates NR Neuroimaging Clin N Am; 1996 Feb; 6(1):61-72. PubMed ID: 8919134 [TBL] [Abstract][Full Text] [Related]
8. [Immunopathology of Graves'-Basedow disease]. Baj Z; Ferenc T; Lewiński A Postepy Hig Med Dosw; 1997; 51(5):531-46. PubMed ID: 9489453 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO). Giovanella L; Ceriani L; Garancini S Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370 [TBL] [Abstract][Full Text] [Related]
10. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre. Wallaschofski H; Kuwert T; Lohmann T Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319 [TBL] [Abstract][Full Text] [Related]
11. Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves' ophthalmopathy. Heufelder AE Thyroid; 1995 Aug; 5(4):331-40. PubMed ID: 7488878 [TBL] [Abstract][Full Text] [Related]
12. [Effect of the treatment of hyperthyroidism on the course of exophthalmos]. Vázquez-Chávez C; Nishimura Meguro E; Espinosa Said L; Delgado Falfari A; Sáinz de Viteri M Rev Invest Clin; 1992; 44(2):241-7. PubMed ID: 1439313 [TBL] [Abstract][Full Text] [Related]
13. [Ocular hypertension in patients with infiltrative-edematous exophthalmos in Graves' disease]. Janik J; Wasowska M; Zgliczyński S; Górowski T; Jastrzebska H Klin Oczna; 1990 Aug; 92(3-4):46-7. PubMed ID: 2263032 [TBL] [Abstract][Full Text] [Related]
14. Unique properties of orbital connective tissue underlie its involvement in Graves' disease. Smith TJ Minerva Endocrinol; 2003 Sep; 28(3):213-22. PubMed ID: 14605603 [TBL] [Abstract][Full Text] [Related]
15. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor. Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288 [TBL] [Abstract][Full Text] [Related]
16. Thyroid eye disease. Eye series--10. Hodge C; Martin P Aust Fam Physician; 2003 Nov; 32(11):939-40. PubMed ID: 14650793 [No Abstract] [Full Text] [Related]
17. Thyroid cancer yield in patients with Graves' disease. Stocker DJ; Burch HB Minerva Endocrinol; 2003 Sep; 28(3):205-12. PubMed ID: 14605602 [TBL] [Abstract][Full Text] [Related]
18. [Thyroid antibodies and their diagnostic value]. Schneidinger P; Joller-Jemelka H; Grob PJ Schweiz Med Wochenschr; 1985 Nov; 115(44):1536-44. PubMed ID: 3841229 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic criteria for Graves' ophthalmopathy. Bartley GB; Gorman CA Am J Ophthalmol; 1995 Jun; 119(6):792-5. PubMed ID: 7785696 [TBL] [Abstract][Full Text] [Related]
20. Original acquisition in the pathogenesis and the treatment of endocrine ophthalmopathy. Winand RJ; Cornet G; Etienne-Decerf J; Wadeleux P; Glinoer D Metab Pediatr Syst Ophthalmol (1985); 1988; 11(3):126-32. PubMed ID: 3205167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]